These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 12555073
1. An inhibitory function for JNK in the regulation of IGF-I signaling in breast cancer. Mamay CL, Mingo-Sion AM, Wolf DM, Molina MD, Van Den Berg CL. Oncogene; 2003 Jan 30; 22(4):602-14. PubMed ID: 12555073 [Abstract] [Full Text] [Related]
2. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I. Sachdev D, Li SL, Hartell JS, Fujita-Yamaguchi Y, Miller JS, Yee D. Cancer Res; 2003 Feb 01; 63(3):627-35. PubMed ID: 12566306 [Abstract] [Full Text] [Related]
3. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration. Cui X, Kim HJ, Kuiatse I, Kim H, Brown PH, Lee AV. Cancer Res; 2006 May 15; 66(10):5304-13. PubMed ID: 16707456 [Abstract] [Full Text] [Related]
4. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Bartucci M, Morelli C, Mauro L, Andò S, Surmacz E. Cancer Res; 2001 Sep 15; 61(18):6747-54. PubMed ID: 11559546 [Abstract] [Full Text] [Related]
5. IRS-1 expression and activation are not sufficient to activate downstream pathways and enable IGF-I growth response in estrogen receptor negative breast cancer cells. Jackson JG, Yee D. Growth Horm IGF Res; 1999 Oct 15; 9(5):280-9. PubMed ID: 10543935 [Abstract] [Full Text] [Related]
6. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival. Chandrasekher G, Sailaja D. Invest Ophthalmol Vis Sci; 2004 Oct 15; 45(10):3577-88. PubMed ID: 15452065 [Abstract] [Full Text] [Related]
7. PKCdelta and mTOR interact to regulate stress and IGF-I induced IRS-1 Ser312 phosphorylation in breast cancer cells. Mingo-Sion AM, Ferguson HA, Koller E, Reyland ME, Van Den Berg CL. Breast Cancer Res Treat; 2005 Jun 15; 91(3):259-69. PubMed ID: 15952059 [Abstract] [Full Text] [Related]
8. IGF-1 activates hEAG K(+) channels through an Akt-dependent signaling pathway in breast cancer cells: role in cell proliferation. Borowiec AS, Hague F, Harir N, Guénin S, Guerineau F, Gouilleux F, Roudbaraki M, Lassoued K, Ouadid-Ahidouch H. J Cell Physiol; 2007 Sep 15; 212(3):690-701. PubMed ID: 17520698 [Abstract] [Full Text] [Related]
9. Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 3-kinase/AKT pathway. del Rincón SV, Rousseau C, Samanta R, Miller WH. Oncogene; 2003 May 29; 22(22):3353-60. PubMed ID: 12776186 [Abstract] [Full Text] [Related]
10. Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells. Guvakova MA, Surmacz E. Exp Cell Res; 1997 Feb 25; 231(1):149-62. PubMed ID: 9056422 [Abstract] [Full Text] [Related]
11. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity. Salatino M, Schillaci R, Proietti CJ, Carnevale R, Frahm I, Molinolo AA, Iribarren A, Charreau EH, Elizalde PV. Oncogene; 2004 Jul 01; 23(30):5161-74. PubMed ID: 15122317 [Abstract] [Full Text] [Related]
12. RNAi-mediated silencing of insulin receptor substrate 1 (IRS-1) enhances tamoxifen-induced cell death in MCF-7 breast cancer cells. Cesarone G, Garofalo C, Abrams MT, Igoucheva O, Alexeev V, Yoon K, Surmacz E, Wickstrom E. J Cell Biochem; 2006 May 15; 98(2):440-50. PubMed ID: 16440325 [Abstract] [Full Text] [Related]
13. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells. Batty IH, Fleming IN, Downes CP. Biochem J; 2004 May 01; 379(Pt 3):641-51. PubMed ID: 14769130 [Abstract] [Full Text] [Related]
14. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R. Int J Oncol; 2004 Mar 01; 24(3):591-608. PubMed ID: 14767544 [Abstract] [Full Text] [Related]
15. Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signaling. Sharfi H, Eldar-Finkelman H. Am J Physiol Endocrinol Metab; 2008 Feb 01; 294(2):E307-15. PubMed ID: 18029441 [Abstract] [Full Text] [Related]
16. Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines. Jackson JG, Zhang X, Yoneda T, Yee D. Oncogene; 2001 Nov 01; 20(50):7318-25. PubMed ID: 11704861 [Abstract] [Full Text] [Related]
19. Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling. Pandini G, Vigneri R, Costantino A, Frasca F, Ippolito A, Fujita-Yamaguchi Y, Siddle K, Goldfine ID, Belfiore A. Clin Cancer Res; 1999 Jul 01; 5(7):1935-44. PubMed ID: 10430101 [Abstract] [Full Text] [Related]